Skip to main content
Premium Trial:

Request an Annual Quote

Theranos' Holmes Indicted

A US federal grand jury has indicted Theranos' Elizabeth Holmes and Ramesh Balwani for alleged wire fraud, as 360Dx reports. It adds that Holmes also stepped down as the company's CEO Friday.

Holmes, who started the company in 2003, and Balwani, its former president, are charged with two counts of conspiracy to commit wire fraud and nine counts of wire fraud. "This indictment alleges a corporate conspiracy to defraud financial investors," John Bennett from the Federal Bureau of Investigation in San Francisco tells the Wall Street Journal. "More egregiously, this conspiracy misled doctors and patients about the reliability of medical tests that endangered health and lives."

Both Holmes and Balwani have pleaded not guilty, the New York Times adds.

Theranos, which was once valued at $9 billion as it claimed to be able to conduct a suite of blood tests from a small amount of blood, began to unravel following a series of articles in the Wall Street Journal that reported that its technology and lab practices might not be up to snuff. The Centers for Medicare & Medicaid Services in January 2016 sent the firm a letter about a number of deficiencies in its lab testing procedures and later barred Holmes from owning or operating a lab for two years.

The Securities and Exchange Commission also charged Theranos, Holmes, and Balwani with fraud in March. While Holmes and Theranos settled the case, Balwani indicated he would fight it, 360Dx adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.